印度迪氏曼 Dishman Pharmaceuticals & Chemicals公司
作为迪氏曼集团进军中国的第一步。迪氏曼集团于2004年2月在上海外高桥保税区注册成立了全资子公司——迪氏曼国际贸易（上海）有限公司。经过近四年的不泄努力，目前中国已成为迪氏曼集团全球化工原料最主要的采购地。同时面对中国这个巨大的潜在市场，迪氏曼集团决定进一步将生产基地延伸到中国，并于2006年9月在上海化工园区投资成立全资工厂：迪氏曼医药和化工（上海）有限公司。该公司占地75000平方米，依托印度总公司成功获得GMP证书及美国FDA认证的经验，主要生产原料药，医药中间体，季磷盐及季铵盐产品。

Dishman Pharmaceuticals & Chemicals公司（印度Mumbai）也正在打造其全球委托生产生意。公司收购了IO3公司，该公司致力于臭氧化学。IO3S公司现在的资产（不包括对资产的再评估）为200万美元，收购价低于这个价格。2005年，Dishman公司收购了英国曼彻斯特的委托研发公司Synprotec公司。Dishman公司还完成了一个面积7500平方英尺的研发中心，包括一个新CGMP试验工厂和公司产品Bavla在印度的CGMP生产部门。

Dishman Pharmaceutical & Chemicals Ltd, is a globally-focused company, involved in the manufacture of APIs (active pharmaceutical ingredients), API intermediates, quaternary compounds and fine chemicals. Headquartered in Ahmedabad, India, Dishman has exports spanning all continents.

Dishman is a quality conscious, fast growing, R&D intensive organization with a progressive approach. Our continuous progress has been achieved through the skills of our workforce, commitment to new technologies and dedication to good customer service.
Since 1998, Dishman has diversified its interests to contract research and manufacture sector. Within a short span of 5 years, Dishman has achieved several contract research and manufacturing projects and is all set to emerge as India’s leading CMO organization (Contract Manufacturing Outsourcing). Dishman is already established as a respected and preferred outsourcing partner to various pharma majors.